Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer

被引:0
|
作者
Greenup, Rachel Adams
Bardia, Aditya
Buckley, Julliette M.
Niemierko, Andrzej
Camp, Melissa
Coopey, Suzanne
Gadd, Michele
Schapira, Lidia
Taghian, Alphonse G.
Smith, Barbara L.
Specht, Michelle Connolly
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1122
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Gregor, M. Chavez-Mac
    Brown, E. N.
    Lei, X.
    Hsu, L.
    Meric-Bernstam, F.
    Litton, J.
    Mittendorf, E. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. CANCER RESEARCH, 2010, 70
  • [22] Metabolic profile in Mexican young women breast cancer (YWBC) to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC).
    Cruz-Ramos, Marlid
    Nambo-Venegas, Rafel
    Yair Campos-Salgado, Jose
    Ruiz-Godoy, Luz
    Enriquez-Carcamo, Victoria
    Mohar, Alejandro
    Villarreal-Garza, Cynthia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
    Kim, M. M.
    Allen, P.
    Gonzalez-Angulo, A. M.
    Woodward, W. A.
    Meric-Bernstam, F.
    Buzdar, A. U.
    Hunt, K. K.
    Kuerer, H. M.
    Litton, J. K.
    Hortobagyi, G. N.
    Buchholz, T. A.
    Mittendorf, E. A.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (08) : 1999 - 2004
  • [24] Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
    Hatzis, Christos
    Symmans, W. Fraser
    Zhang, Ya
    Gould, Rebekah E.
    Moulder, Stacy L.
    Hunt, Kelly K.
    Abu-Khalaf, Maysa
    Hofstatter, Erin W.
    Lannin, Donald
    Chagpar, Anees B.
    Pusztai, Lajos
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (01) : 26 - 33
  • [25] A model to predict axillary nodal pathologic complete response following neoadjuvant chemotherapy for breast cancer.
    Kantor, Olga
    McNulty, Lynn
    Yao, Katharine
    James, Ted A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Risk factors of breast cancer recurrence in pathologic complete response achieved patients following neoadjuvant chemotherapy
    Choi, J. Y.
    Woen, D.
    Jang, S. Y.
    Lee, H.
    Shin, D. S.
    Kwak, Y.
    Chae, B. -J.
    Yu, J.
    Kim, S. W.
    Lee, J. E.
    Nam, S. J.
    Ryu, J. M.
    [J]. BREAST, 2023, 68 : S72 - S72
  • [27] Bcl-2 Downregulation Is Predictive of Complete Pathologic Response Following Neoadjuvant Chemotherapy in Breast Cancer
    Goodman, S.
    Stockl, T.
    Lyle, S.
    Kandil, D.
    Edmiston, K.
    Quinlan, R.
    Khan, A.
    [J]. MODERN PATHOLOGY, 2013, 26 : 45A - 45A
  • [28] Bcl-2 Downregulation Is Predictive of Complete Pathologic Response Following Neoadjuvant Chemotherapy in Breast Cancer
    Goodman, S.
    Stockl, T.
    Lyle, S.
    Kandil, D.
    Edmiston, K.
    Quinlan, R.
    Khan, A.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 45A - 45A
  • [29] Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer
    Litton, Jennifer K.
    Gonzalez-Angulo, Ana M.
    Warneke, Carla L.
    Buzdar, Aman U.
    Kau, Shu-Wan
    Bondy, Melissa
    Mahabir, Somdat
    Hortobagyi, Gabriel N.
    Brewster, Abenaa M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4072 - 4077
  • [30] A Case of Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Metaplastic Breast Cancer
    Gul, Anita
    Alberty-Oller, J. Jaime
    Sandhu, Jagbir
    Ayala-Bustamante, Everick
    Adams, Sylvia
    [J]. JCO PRECISION ONCOLOGY, 2023, 7